SOLUGEN INC for SOLUGEN INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Support the use of bio-based chemicals in the Department of Defense, generally. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY HOLBROOK | — |
| BRYAN J. SOUKUP | — |
Environment/Superfund ENV
Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-182) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY HOLBROOK | — |
| BRYAN J. SOUKUP | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.